Cape Henlopen Dermatology Is First in Delaware to Offer Nonsurgical Treatment for Common Skin Cancer

BURR RIDGE, Ill., Oct. 25, 2023 /PRNewswire/ -- SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT), the most advanced nonsurgical treatment for common skin cancer, today announced its availability in Delaware at an event at Cape Henlopen Dermatology in Lewes. This is the first medical practice in the state to offer the GentleCure™ treatment experience.  

Image-Guided SRT is the only treatment for nonmelanoma skin cancer (basal and squamous cell carcinoma) that uses ultrasound imaging to help clinicians direct low-level x-rays to targeted areas of the skin, killing cancer cells without bleeding, pain, surgical scarring or need for reconstructive surgery. A study published in the journal Oncology and Therapy showed that Image-Guided SRT produces a 99.3 percent cure rate for early stage nonmelanoma, making it just as effective as traditional surgical treatment.

Kathryn O'Reilly, M.D., Ph.D., of Cape Henlopen Dermatology, noted, "Some 8,500 Delawareans are expected to be diagnosed with nonmelanoma skin cancer this year alone. It is essential for them to have information on all available treatment options, both surgical and nonsurgical, so they can make informed decisions about their care. Image-Guided SRT is one of the most exciting technological innovations in dermatology today. We call it the GentleCure experience, and we are proud to be the first in Delaware to offer it."

Practice co-owner Mitchell Stickler, M.D., added, "For individuals who are fearful of surgery and for those whose other medical conditions make them poor candidates for Mohs surgery, noninvasive Image-Guided SRT is a much-needed option. As we diagnose over 150 nonmelanoma skin cancers per month here at Cape Henlopen Dermatology, Image-Guided SRT is a very welcome tool to add to our armamentarium against the local skin cancer epidemic. We are pleased to be the first practice to offer this technology in the First State."

Also speaking at the event was Lewes City Councilman Khalil Saliba, who said, "This is a very exciting development for the Town of Lewes and our surrounding communities, and I congratulate Drs. O'Reilly and Stickler for their vision and diligence in introducing this cutting-edge treatment to the state of Delaware. Skin cancer is a constant concern in active communities like Lewes. Our bike trails, beaches, and other outdoor activities increase the risks of sun exposure, so this new treatment is welcome, particularly since Delaware residents will no longer need to travel to other states to access this advanced technology."

"We at SkinCure Oncology are delighted to partner with Cape Henlopen Dermatology to offer this highly effective, noninvasive treatment option for their patients," said Kerwin Brandt, Chief Executive Officer of the Chicago-based company. "Patients everywhere should have the choice of curing their nonmelanoma skin cancer without surgery."

About SkinCure Oncology
SkinCure Oncology is the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT), the most advanced nonsurgical treatment for common skin cancer. The company partners with quality-focused dermatologists, Mohs surgeons and other physicians to bring cancer center-level radiation therapy treatment to private practices. Presented to patients as the GentleCure™ experience, Image-Guided SRT is available from some 500 physicians nationwide, with more than 65,000 patients having been treated. Learn more about the company at SkinCureOncology.com, and visit GentleCure.com for helpful consumer and patient information.

Media Contact:
Matt Russell
Russell Public Communications
520-232-9840
[email protected] 

SOURCE SkinCure Oncology